HomeCompareLUMO vs EPRT

LUMO vs EPRT: Dividend Comparison 2026

LUMO yields 46.08% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LUMO wins by $257.8K in total portfolio value
10 years
LUMO
LUMO
● Live price
46.08%
Share price
$4.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$321.2K
Annual income
$60,965.20
Full LUMO calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — LUMO vs EPRT

📍 LUMO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLUMOEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LUMO + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LUMO pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LUMO
Annual income on $10K today (after 15% tax)
$3,917.05/yr
After 10yr DRIP, annual income (after tax)
$51,820.42/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, LUMO beats the other by $40,905.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LUMO + EPRT for your $10,000?

LUMO: 50%EPRT: 50%
100% EPRT50/50100% LUMO
Portfolio after 10yr
$192.3K
Annual income
$36,902.96/yr
Blended yield
19.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

LUMO
No analyst data
Price Target
$16.50
+280.2% upside vs current
Range: $7.00 — $26.00
Altman Z
-19.2
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LUMO buys
0
EPRT buys
0
No recent congressional trades found for LUMO or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLUMOEPRT
Forward yield46.08%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$321.2K$63.4K
Annual income after 10y$60,965.20$12,840.73
Total dividends collected$251.2K$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst price target$16.50$35.50

Year-by-year: LUMO vs EPRT ($10,000, DRIP)

YearLUMO PortfolioLUMO Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$15,308$4,608.29$11,205$505.18+$4.1KLUMO
2$22,973$6,593.00$12,672$682.46+$10.3KLUMO
3$33,828$9,246.73$14,490$930.48+$19.3KLUMO
4$48,921$12,725.11$16,786$1,282.69+$32.1KLUMO
5$69,544$17,198.81$19,753$1,791.56+$49.8KLUMO
6$97,262$22,849.74$23,677$2,541.64+$73.6KLUMO
7$133,936$29,866.21$29,008$3,672.99+$104.9KLUMO
8$181,749$38,437.25$36,463$5,425.08+$145.3KLUMO
9$243,218$48,746.39$47,238$8,221.57+$196.0KLUMO
10$321,208$60,965.20$63,385$12,840.73+$257.8KLUMO

LUMO vs EPRT: Complete Analysis 2026

LUMOStock

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Full LUMO Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this LUMO vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LUMO vs SCHDLUMO vs JEPILUMO vs OLUMO vs KOLUMO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.